Stay updated on Upadacitinib vs Methotrexate in RA Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in RA Clinical Trial page
- Check4 days agoChange DetectedThe related topics section no longer lists 'Rheumatoid arthritis' and 'MedlinePlus Genetics', removing some navigational links to disease-related information.SummaryDifference0.1% 
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedCitation metadata updated: publication date/status changed from “Online ahead of print” to a finalized/updated date, with minor timing adjustment; core content and authors remain the same.SummaryDifference0.2% 
- Check25 days agoChange DetectedThe page version was updated from v3.1.0 to v3.2.0, and a new government-status notice was added describing potential delays and updated operating status for NIH Clinical Center, with links for official updates.SummaryDifference2% 
- Check32 days agoChange DetectedAdd: new MedlinePlus Genetics topic on Rheumatoid arthritis and version upgrade to v3.1.0. Remove: old version v3.0.2.SummaryDifference0.1% 
- Check40 days agoChange DetectedRemoved MedlinePlus Genetics topics related to Rheumatoid arthritis; overall, a loss of content about that condition.SummaryDifference0.1% 
- Check47 days agoChange DetectedUpdated to v3.0.2 and added a MedlinePlus Genetics topic on Rheumatoid arthritis; removed the Back to Top navigation.SummaryDifference0.2% 
Stay in the know with updates to Upadacitinib vs Methotrexate in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in RA Clinical Trial page.